Nilsine Partners’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.93M | Buy |
36,611
+31,341
| +595% | +$3.37M | 0.4% | 56 |
|
|
2025
Q1 | $532K | Sell |
5,270
-15
| -0.3% | -$1.51K | 0.06% | 234 |
|
|
2024
Q4 | $472K | Buy |
5,285
+437
| +9% | +$39K | 0.05% | 261 |
|
|
2024
Q3 | $406K | Sell |
4,848
-514
| -10% | -$43.1K | 0.05% | 246 |
|
|
2024
Q2 | $413K | Sell |
5,362
-141
| -3% | -$10.9K | 0.06% | 241 |
|
|
2024
Q1 | $377K | Sell |
5,503
-85
| -2% | -$5.82K | 0.05% | 247 |
|
|
2023
Q4 | $323K | Sell |
5,588
-4,003
| -42% | -$231K | 0.05% | 257 |
|
|
2023
Q3 | $506K | Buy |
9,591
+47
| +0.5% | +$2.48K | 0.08% | 225 |
|
|
2023
Q2 | $516K | Sell |
9,544
-670
| -7% | -$36.2K | 0.08% | 226 |
|
|
2023
Q1 | $511K | Buy |
+10,214
| New | +$511K | 0.08% | 230 |
|